AACR22: As post-Covid development takes shape, BioNTech reports first human data for CAR-T/cancer vaccine combo - Endpoints News

NEW ORLEANS — Continuing to push into new frontiers following the huge success of its Covid-19 vaccine, BioNTech revealed the first-in-human data for its combination CAR-T and mRNA cancer therapy. In a Phase I portion of a Phase I/II study, the German biotech…

Nearly every clinical trial, regardless of indication or phase, should be agile—incorporating technology and decentralized approaches—to make drug and therapy development faster, easier and more repr… [+553 chars]

full article...